Business
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-833-316-1983 Toll/International: 1-785-838-9310 Conference ID
About this update from Sanuwave Health, Inc.
[{"type":"image","alt":"SANUWAVE Health, Inc.","displaySize":"","headline":null,"caption":"SANUWAVE Health, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/fd255a24ecd09cb8a9746f28b56b9952"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GYJVr.PJBcqACVEZp68t1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkw/https://media.zenfs.com/en/globenewswire.com/fd255a24ecd09cb8a9746f28b56b9952","width":300,"height":64}},"lazy":false},{"type":"text","content":"EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results.","length":327,"tagName":"p"},{"type":"text","content":"Telephone access to the call will be available by dialing the following numbers:","length":80,"tagName":"p"},{"type":"text","content":"Participant Dial-in Information ","length":31,"tagName":"p"},{"type":"text","content":"Toll Free: 1-833-316-1983","length":25,"tagName":"p"},{"type":"text","content":"Toll/International: 1-785-838-9310","length":34,"tagName":"p"},{"type":"text","content":"Conference ID: SANUWAVE","length":23,"tagName":"p"},{"type":"text","content":"OR click the link below to access the live webcast:https://viavid.webcasts.com/starthere.jsp?ei=1762392&tp_key=537d7338d6","length":126,"tagName":"p"},{"type":"text","content":"Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.","length":111,"tagName":"p"},{"type":"text","content":"A replay will be made available through Wednesday, May 27, 2026:","length":64,"tagName":"p"},{"type":"text","content":"Toll-Free: 1-844-512-2921 or 1-412-317-6671","length":43,"tagName":"p"},{"type":"text","content":"Replay Access ID: 11161765","length":26,"tagName":"p"},{"type":"text","content":"About Sanuwave","length":14,"tagName":"p"},{"type":"text","content":"Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.","length":249,"tagName":"p"}...